Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadahiro Naka

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Annals of Nuclear Medicine|March 2, 2019
Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2Masanao Aoki, Tadashi Watabe, Shushi Nagamori, et al.
Plos One|September 17, 2014
Distribution of intravenously administered acetylcholinesterase inhibitor and acetylcholinesterase activity in the adrenal gland: 11C-donepezil PET study in the normal ratTadashi Watabe, Sadahiro Naka, Hayato Ikeda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2025
Theranostics using <sup>89</sup>Zr/<sup>177</sup>Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)Tadashi Watabe, Takumi Iwasawa, Hiroyuki Kimura, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2016
<sup>18</sup>F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with <sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PETTadashi Watabe, Hayato Ikeda, Shushi Nagamori, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 24, 2019
Impact of <sup>18</sup>F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on MiceFumihiko Soeda, Tadashi Watabe, Sadahiro Naka, et al.
EJNMMI Radiopharmacy and Chemistry|April 15, 2024
Production of [<sup>211</sup>At]NaAt solution under GMP compliance for investigator-initiated clinical trialSadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, et al.
EJNMMI Radiopharmacy and Chemistry|August 22, 2021
One-pot and one-step automated radio-synthesis of [<sup>18</sup>F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experimentSadahiro Naka, Tadashi Watabe, Thomas Lindner, et al.
Nuclear Medicine and Biology|March 19, 2026
Enhanced tumor retention of the novel LAT1-targeting PET probe [<sup>18</sup>F]FAMT-OMe: A comparative study with [<sup>18</sup>F]FAMT in glioma mouse modelsThosapol Sampunta, Tadashi Watabe, Sadahiro Naka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2021
Fibroblast activation protein targeted therapy using [<sup>177</sup>Lu]FAPI-46 compared with [<sup>225</sup>Ac]FAPI-46 in a pancreatic cancer modelYuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, et al.
Annals of Nuclear Medicine|March 4, 2021
High detection rate in [<sup>18</sup>F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patientsTadashi Watabe, Motohide Uemura, Fumihiko Soeda, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Annals of Nuclear Medicine|March 2, 2019
Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2Masanao Aoki, Tadashi Watabe, Shushi Nagamori, et al.
Plos One|September 17, 2014
Distribution of intravenously administered acetylcholinesterase inhibitor and acetylcholinesterase activity in the adrenal gland: 11C-donepezil PET study in the normal ratTadashi Watabe, Sadahiro Naka, Hayato Ikeda, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2025
Theranostics using <sup>89</sup>Zr/<sup>177</sup>Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)Tadashi Watabe, Takumi Iwasawa, Hiroyuki Kimura, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2016
<sup>18</sup>F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with <sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PETTadashi Watabe, Hayato Ikeda, Shushi Nagamori, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 24, 2019
Impact of <sup>18</sup>F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on MiceFumihiko Soeda, Tadashi Watabe, Sadahiro Naka, et al.
EJNMMI Radiopharmacy and Chemistry|April 15, 2024
Production of [<sup>211</sup>At]NaAt solution under GMP compliance for investigator-initiated clinical trialSadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, et al.
EJNMMI Radiopharmacy and Chemistry|August 22, 2021
One-pot and one-step automated radio-synthesis of [<sup>18</sup>F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experimentSadahiro Naka, Tadashi Watabe, Thomas Lindner, et al.
Nuclear Medicine and Biology|March 19, 2026
Enhanced tumor retention of the novel LAT1-targeting PET probe [<sup>18</sup>F]FAMT-OMe: A comparative study with [<sup>18</sup>F]FAMT in glioma mouse modelsThosapol Sampunta, Tadashi Watabe, Sadahiro Naka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2021
Fibroblast activation protein targeted therapy using [<sup>177</sup>Lu]FAPI-46 compared with [<sup>225</sup>Ac]FAPI-46 in a pancreatic cancer modelYuwei Liu, Tadashi Watabe, Kazuko Kaneda-Nakashima, et al.
Annals of Nuclear Medicine|March 4, 2021
High detection rate in [<sup>18</sup>F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patientsTadashi Watabe, Motohide Uemura, Fumihiko Soeda, et al.
Pageof 5